Trial Profile
Defining the interaction of docetaxel and lonafarnib in patients with advanced malignancies
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Lonafarnib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 21 Jul 2006 New trial record.